TP53 acquired mutations have been shown to affect a plethora of cancers including colon, stomach, breast, lung, brain, and esophageal cancers, and estimations indicate that over 50% of all cancer cases contain TP53 mutations (154–159). Here, TP53 is linked to cancer.